Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355739
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-02-02
Brief Title:
CD19-targeted CAR T Cell Autotransfusion for the Treatment of RecurrentRefractory B-cell Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma in Children With CD19
Sponsor:
Zhu Xiaofan
Organization:
Institute of Hematology Blood Diseases Hospital China
Organization Data
Organization:
Institute of Hematology Blood Diseases Hospital China
Class:
OTHER
Study ID:
BIC-19GG BIC-2019BIC-2219
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zhu Xiaofan
Lead Sponsor Class:
OTHER
Responsible Party:
Zhu Xiaofan
Responsible Party Title:
Head of department
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Institute of Hematology Blood Diseases Hospital China
Old Name:
None
Old Organization:
None